These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35453591)

  • 41. Clinical and pathological features of pachyonychia congenita.
    Leachman SA; Kaspar RL; Fleckman P; Florell SR; Smith FJ; McLean WH; Lunny DP; Milstone LM; van Steensel MA; Munro CS; O'Toole EA; Celebi JT; Kansky A; Lane EB
    J Investig Dermatol Symp Proc; 2005 Oct; 10(1):3-17. PubMed ID: 16250204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defective cathepsin Z affects EGFR expression and causes autosomal dominant palmoplantar keratoderma.
    Malovitski K; Sarig O; Feller Y; Bergson S; Assaf S; Mohamad J; Pavlovsky M; Giladi M; Sprecher E
    Br J Dermatol; 2023 Aug; 189(3):302-311. PubMed ID: 37210216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of pachyonychia congenita with unusual manifestations: an unusual type or a new syndrome?
    Gönül M; Gül Ü; Kılıç A; Soylu S; Koçak O; Demiriz M
    Int J Dermatol; 2015 Mar; 54(3):334-7. PubMed ID: 25713981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of pachyonychia congenita with oral leukoplakia and steatocystoma multiplex.
    Lim TW; Paik JH; Kim NI
    J Dermatol; 1999 Oct; 26(10):677-81. PubMed ID: 10554435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of botulinum toxin in pachyonychia congenita type 1: report of two new cases.
    González-Ramos J; Sendagorta-Cudós E; González-López G; Mayor-Ibarguren A; Feltes-Ochoa R; Herranz-Pinto P
    Dermatol Ther; 2016; 29(1):32-6. PubMed ID: 26445325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systematic review of reported cases of pachyonychia congenita tarda.
    Tatiane A; Slape D; Lawless R; Frew JW
    Clin Exp Dermatol; 2019 Aug; 44(6):606-612. PubMed ID: 31074523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.
    Wu TT; Eldirany SA; Bunick CG; Teng JMC
    J Invest Dermatol; 2021 Dec; 141(12):2876-2884.e4. PubMed ID: 34116063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.
    Spaunhurst KM; Hogendorf AM; Smith FJ; Lingala B; Schwartz ME; Cywinska-Bernas A; Zeman KJ; Tang JY
    Br J Dermatol; 2012 Apr; 166(4):875-8. PubMed ID: 22098151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pachyonychia congenita responding favorably to a combination of surgical and medical therapies.
    Daroach M; Dogra S; Bhattacharjee R; Tp A; Smith F; Mahajan R
    Dermatol Ther; 2019 Sep; 32(5):e13045. PubMed ID: 31364784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Painful thickened skin on the soles of the feet.
    Nicholson LT; Topham C; Curtis J; Madigan LM
    JAAD Case Rep; 2022 Nov; 29():146-148. PubMed ID: 36275875
    [No Abstract]   [Full Text] [Related]  

  • 51. Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma.
    Zieman AG; Poll BG; Ma J; Coulombe PA
    Hum Mol Genet; 2019 Jul; 28(13):2255-2270. PubMed ID: 31220272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutation of a type II keratin gene (K6a) in pachyonychia congenita.
    Bowden PE; Haley JL; Kansky A; Rothnagel JA; Jones DO; Turner RJ
    Nat Genet; 1995 Jul; 10(3):363-5. PubMed ID: 7545493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma.
    Koren A; Sprecher E; Reider E; Artzi O
    Br J Dermatol; 2020 Mar; 182(3):671-677. PubMed ID: 31127950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita.
    Terrinoni A; Smith FJ; Didona B; Canzona F; Paradisi M; Huber M; Hohl D; David A; Verloes A; Leigh IM; Munro CS; Melino G; McLean WH
    J Invest Dermatol; 2001 Dec; 117(6):1391-6. PubMed ID: 11886499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An appraisal of oral retinoids in the treatment of pachyonychia congenita.
    Gruber R; Edlinger M; Kaspar RL; Hansen CD; Leachman S; Milstone LM; Smith FJ; Sidoroff A; Fritsch PO; Schmuth M
    J Am Acad Dermatol; 2012 Jun; 66(6):e193-9. PubMed ID: 21601946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case with pachyonychia congenita and B-cell lymphoma.
    dos Santos VM; Loures TP; Rego JD; Teixeira CA; de Carvalho KD; Nascimento AL
    Acta Med Iran; 2014; 52(7):578-81. PubMed ID: 25135271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular epidemiology of pachyonychia congenita in the Israeli population.
    Pavlovsky M; Peled A; Samuelov L; Malki L; Malovitski K; Assaf S; Mohamad J; Meijers O; Eskin-Schwartz M; Sarig O; Sprecher E
    Clin Exp Dermatol; 2021 Jun; 46(4):663-668. PubMed ID: 33190296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study of high-resolution multifrequency ultrasound of the plantar skin in patients with various types of hereditary palmoplantar keratoderma.
    Goldberg I; Sprecher E; Schwartz ME; Gaitini D
    Dermatology; 2013; 226(4):365-70. PubMed ID: 24030314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A large mutational study in pachyonychia congenita.
    Wilson NJ; Leachman SA; Hansen CD; McMullan AC; Milstone LM; Schwartz ME; McLean WH; Hull PR; Smith FJ
    J Invest Dermatol; 2011 May; 131(5):1018-24. PubMed ID: 21326300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Painful plantar keratoderma and onychodystrophy in caucasian young woman].
    De Asís Cuestas S; Mateu-Puchades A; Marquina-Vila A
    Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.